Phase 2 Study of Anakinra to Prevent CRS and Neurotoxicity after Treatment with Lisocabtagene Maraleucel: Planned Interim AnalysisJordan Gauthier, Aya Albittar, Andrew J. Portuguese et al.|Blood|2023Cited by 2
Planned Interim Analysis of a Phase 2 Investigator-Initiated Trial of Anakinra to Prevent CRS and Neurotoxicity after Treatment with Lisocabtagene MaraleucelEmily C. Liang, Jordan Gauthier, Joseph De Los Reyes et al.|Transplantation and Cellular Therapy|2024Cited by 2
Machine Learning-Based Time-Series Clustering Identifies Archetypal Trajectories of Hematotoxicity after CAR T-Cell TherapyJordan Gauthier, Aya Albittar, Andrew J. Portuguese et al.|Blood|2023Cited by 0
Identification and Prediction of Severe Hematologic Toxicity after CAR T-Cell Therapy Using Machine Learning-Based Time-Series ClusteringEmily C. Liang, Jordan Gauthier, Aya Albittar et al.|Transplantation and Cellular Therapy|2024Cited by 0